Skip to main content
. 2021 Apr 13;21:401. doi: 10.1186/s12885-021-08138-3

Fig. 5.

Fig. 5

Performance of PIVKA-II in the diagnosis of AFP-negative HCC patients. ROC of PIVKA-II to distinguish HCC AFP-negative from healthy controls (HC) (a), and benign liver diseases (BLD) (b) respectively